Form: 3

Initial statement of beneficial ownership of securities

May 2, 2011

Documents

FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  JONES STEVEN C
 2. Date of Event Requiring Statement (Month/Day/Year)
05/02/2011		 3. Issuer Name and Ticker or Trading Symbol
NEOGENOMICS INC [NGNM]
(Last)
(First)
(Middle)
C/O NEOGENOMICS, INC. 12701, COMMONWEALTH DRIVE SUITE 9		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive VP of Finance
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

FORT MYERS, FL 33913		 6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 403,804
D
 
Common Stock 8,038,123
I
By Aspen Select Healthcare, LP (1)
Common Stock 129,412
I
By Aspen Opportunity Fund, LP (2)
Common Stock 90,000
I
By self as Trustee for Steven and Carisa Jones Defined Benefit Plan & Trust
Common Stock 50,476
I
By Jones Network, LP (2)
Common Stock 32,157
I
Shares owned in IRA and custodian accounts for the immediate family of Steven Jones.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (right to buy) 06/07/2007 06/07/2012 6/7/2012 350,000 $ 1.5 D  
Warrant (right to buy) 05/03/2010(3) 05/03/2017 Common Stock 450,000 $ 1.5 D  
Warrant (right to buy) 02/09/2009 02/09/2014 Common Stock 83,333 $ 0.75 I By Gulf Pointe Capital, LLC (2)

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
JONES STEVEN C
C/O NEOGENOMICS, INC. 12701
COMMONWEALTH DRIVE SUITE 9
FORT MYERS, FL 33913		   X   X   Executive VP of Finance  
ASPEN SELECT HEALTHCARE LP
ASPEN SELECT HEALTHCARE, L.P. C/O ASPEN
CAPITAL GROUP, 1740 PERSIMMON DR. #100
NAPLES, FL 34109		     X    

Signatures

/s/ Steven C. Jones 05/02/2011
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
(2) An investment partnership entity controlled by Steven Jones and Peter Peterson.. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
(3) Such warrants were issued in connection with a consulting agreement, dated 5/3/2010. 225,000 of such warrants were vested as of the date of the agreement for prior service. 112,500 of such warrants are subject to pro rata monthly vesting over a 24 month period beginning in May 2010 and ending in April 2012. 112,500 of such warrants are subject to performance vesting based on whether NeoGenomics meets certain financial performance goals over a two year vesting period.
 
Remarks:
Steven Jones and Aspen Select Healthcare, LP are joint filers, as permitted under Rule 16(a)-3(j) of the Securities Exchange
 Act of 1934, as amended.

Exhibit List
Exhibit 99 - Joint Filer Information

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.